Walker & Dunlop, Inc. quarterly report, Q1 FY2024

Walker & Dunlop, Inc. — Q1 2024 Form 10-Q

Reporting period: Three months ended March 31, 2024; comparisons are with Q1 2023 unless noted. Walker & Dunlop provides commercial real estate financing, brokerage, servicing, investment management, and affordable-housing services. Results are interim and are not necessarily indicative of full-year performance.

Financial performance

MetricQ1 2024Q1 2023Change
Total revenue$228.1 million$238.7 millionDown 4%
Income from operations$13.7 million$34.6 millionDown 60%
Walker & Dunlop net income$11.9 million$26.7 millionDown 55%
Diluted EPS$0.35$0.79Down 56%
Adjusted EBITDA$74.1 million$68.0 millionUp 9%; non-GAAP
Operating margin6%14%Down 8 percentage points
Operating cash flow$38.4 million$(546.7) millionImproved, largely due to loan-sale timing

Revenue was pressured by lower loan-origination and servicing-rights fair-value income, property sales, and other revenue. Servicing fees rose 6% to $80.0 million, while placement fees and other interest income rose 27% to $39.4 million, benefiting from higher short-term rates. Expenses increased 5% to $214.4 million, chiefly because the credit-loss line shifted from a $10.8 million benefit to a $0.5 million provision, and corporate-debt interest and other operating costs increased. Personnel expense fell 6% to $111.5 million.

Debt financing volume increased 8% to $5.23 billion, driven by a 40% increase in brokered volume; property sales volume fell 38% to $1.17 billion. The servicing portfolio grew 6% to $132.0 billion and assets under management were $17.5 billion, up 5%. Segment net income was $43.3 million for Servicing & Asset Management, a 15% decline; Capital Markets recorded a $6.7 million loss versus $0.5 million income a year earlier.

Balance sheet, debt and liquidity

  • At March 31, 2024, cash and cash equivalents were $216.5 million; total cash, including restricted and pledged cash, was $280.6 million, down from $391.4 million at year-end 2023.
  • Total assets were $3.83 billion and total liabilities were $2.09 billion. Warehouse notes payable were $522.0 million and notes payable were $772.0 million on the balance sheet. The company reported $784.5 million of corporate-debt principal outstanding; debt is floating-rate and tied to SOFR.
  • Operating liquidity at Walker & Dunlop, LLC was $177.9 million against a stated minimum requirement of $61.8 million. The company reported compliance with required net-worth, operational-liquidity, warehouse, and credit-agreement covenants.
  • Fannie Mae collateral requirements are expected to require an additional $75.4 million of restricted liquidity over 48 months, assuming no further portfolio changes. The company said it expects operating cash flows to meet its obligations for the foreseeable future.
  • The company paid a $0.65-per-share dividend in Q1 and declared the same dividend for Q2. A $75 million repurchase authorization was approved in February; no shares were repurchased under that program through March 31.

Material changes, outlook and risks

Management described a market constrained by elevated, volatile interest rates, subdued commercial real estate transactions, and uncertainty among owners and lenders. It noted that the 10-year Treasury yield rose to 4.62% in April. The company expects elevated placement-fee income to continue during 2024, and anticipates more competitive GSE terms and improving GSE and HUD activity as rates stabilize. These are management expectations, not formal company financial guidance. The MBA forecast cited in the filing calls for multifamily lending volume to rise to $339 billion in 2024 from $271 billion in 2023; management said that outcome depends on stable rates and substantial second-half activity.

  • Credit and repurchase exposure: The company repurchased a $17.9 million Fannie Mae loan in Q1, recording an immaterial credit provision. It also agreed to indemnify Freddie Mac for two loans with unpaid balances of $11.4 million and $34.8 million. The larger loan involved suspected borrower fraud; the company estimated a $2.0 million indemnification liability and had not completed its property evaluation.
  • Risk-sharing: The allowance for risk-sharing obligations was $30.1 million against a $59.2 billion at-risk Fannie Mae servicing portfolio. Six loans with aggregate unpaid principal of $63.3 million were identified as in default. The stated $12.1 billion maximum contingent exposure assumes all relevant loans default and collateral has no value; it is not management’s estimate of expected losses.
  • Valuation sensitivity: MSR carrying value was $881.8 million. A 100-basis-point increase in the MSR discount rate would reduce estimated fair value by $44.3 million, based on the filing’s sensitivity analysis.
  • Interest-rate risk: A 100-basis-point rise in SOFR was estimated to reduce annual income from operations by $7.8 million on corporate debt; the estimated annual placement-fee benefit from a 100-basis-point rise in the effective Federal Funds Rate was $23.1 million. These sensitivities are not forecasts.
  • Management reported no material changes to the risk factors in its 2023 Form 10-K. Ordinary-course litigation was not believed to be material. Disclosure controls were assessed as effective, with no material change in internal control over financial reporting reported.

Important facts for investors to verify

  • Whether improving GSE, HUD, and broader multifamily transaction activity materializes, particularly in the second half of 2024.
  • Whether recurring servicing and placement-fee growth can offset continued weakness in origination, property sales, and investment-management revenue.
  • The outcome and potential loss from the Freddie Mac indemnifications, including the loan involving suspected fraud, and any further Agency repurchase demands.
  • Actual credit losses versus the risk-sharing allowance, including developments in the six defaulted loans and multifamily property conditions.
  • Cash generation and liquidity after dividends, debt service, acquisition earnouts, and the planned increase in restricted collateral; assess adjusted EBITDA alongside GAAP earnings and cash flows.